Fluoxetine-induced phenytoin toxicity: a clinical reminder about the perils of polypharmacy
Lance, S.; Ternouth, I.
New Zealand Medical Journal 128(1422): 78-79
2015
ISSN/ISBN: 1175-8716 PMID: 26411853 Document Number: 681463
Document emailed within 1 workday
Related Documents
Curtis, D.L.; Piibe, R.; Ellenhorn, M.J.; Wasserberger, J.; Ordog, G. 1989: Phenytoin toxicity: predictors of clinical course Veterinary and Human Toxicology 31(2): 162-163Shaikh, A.S.; Li, Y.; Cao, L.; Guo, R. 2018: Analysis of phenytoin drug concentration for evaluation of clinical response, uncontrolled seizures and toxicity Pakistan Journal of Pharmaceutical Sciences 31(4(Special): 1697-1700
Shuttleworth, E.; Sawyer, R.; Holland, M.; Cooksley, T. 2014: The perils of Grandma's medication: colchicine toxicity causing pneumomediastinum Acute Medicine 13(4): 171-173
Curtis, D.L.; Piibe, R.; Ellenhorn, M.J.; Wasserberger, J.; Ordog, G. 1989: Phenytoin toxicity: a review of 94 cases Veterinary and Human Toxicology 31(2): 164-165
Overduin, L.M. 1992: Clinical trial on sustained-release phenytoin. Preliminary results of the open, non-controlled study. the Phenytoin Trial Group on Canine Epilepsy Tijdschrift Voor Diergeneeskunde 117(Suppl 1): 27s-28s
Arroyo, P.; Ortiz Nolasco, R.; Godoy López, M.; Garcia Gubern, C.; Rivera, V. 2004: A junctional rhythm with retrograde conduction and bradycardia as a dysrhythmia caused by oral phenytoin toxicity Boletin de la Asociacion Medica de Puerto Rico 96(3): 134-138
Shaw, J.A. 2005: Microbial persistence: a clinical reminder American Journal of Orthopedics 34(4): 183-185
Arrojo, M.; Reis, J.J.; Romão, B.; Reis, M.C. 2004: Fluoxetine-induced dystonia Revista de Neurologia 38(1): 99
Dominguez, R.A.; Kumar, A.M.; Cua, W. 1996: Lack of change in fluoxetine and norfluoxetine kinetics when switching from fluoxetine to paroxetine Journal of Clinical Psychopharmacology 16(4): 320-323
Breuel, H.P.; Müller-Oerlinghausen, B.; Nickelsen, T.; Heine, P.R. 1995: Pharmacokinetic interactions between lithium and fluoxetine after single and repeated fluoxetine administration in young healthy volunteers International Journal of Clinical Pharmacology and Therapeutics 33(7): 415-419
Feder, R. 1991: Bradycardia and syncope induced by fluoxetine Journal of Clinical Psychiatry 52(3): 139
Davies, L.P. 1992: Fluoxetine-induced lung damage Medical Journal of Australia 156(10): 740
Patterson, W.M. 1993: Fluoxetine-induced sexual dysfunction Journal of Clinical Psychiatry 54(2): 71
May, D.; Pearson, K.; Durran, A.; Davies, C.; Magan, A.; Knight, J. 2010: Buttock cellulitis as a presentation of psoas abscess: a clinical reminder Acute Medicine 9(2): 82-83
Maneeton, N.; Thongkam, A.; Maneeton, B. 2010: Cognitive-behavioral therapy added to fluoxetine in major depressive disorder after 4 weeks of fluoxetine-treatment: 16-week open label study Journal of the Medical Association of Thailand 93(3): 337-342
Li, A.-M.; Miao, J.-H.; Liu, H.; Ma, Y.-Z.; Sun, Z.-C. 2015: Drug-induced skin toxicity and clinical nursing of VitK cream on colorectal cancer patients Pakistan Journal of Pharmaceutical Sciences 28(4 Suppl): 1499-1503
Kjer, J.J. 1978: Phenytoin-induced agranulocytosis Ugeskrift for Laeger 140(25): 1493
Frentz, G. 1977: Phenytoin-induced acne Ugeskrift for Laeger 139(6): 338-339
Roberts, B.I.; Mathews, C.L.; Walton, C.J.; Frazier, G. 1982: A computer-based maintenance reminder and record-keeping system for clinical laboratories Clinical Chemistry 28(9): 1917-1921
Levo, Y. 1982: Immunologic alterations induced by phenytoin New England Journal of Medicine 307(5): 315-316